Skip to main content
Top
Published in: Journal of General Internal Medicine 9/2019

01-09-2019 | Letter to the Editor

Abnormal Liver Enzymes

Author: Shih-Wei Lai, MD

Published in: Journal of General Internal Medicine | Issue 9/2019

Login to get access

Excerpt

One study by Bian et al. examined the follow-up patterns of abnormal liver enzymes in primary care.1 The authors reported that no association between race and follow-up patterns after an initial abnormal liver test, but approximately 50.7 to 56.5% of people with abnormal liver enzymes did not perform a repeating test.1 In addition, Schreiner et al. reported that 11.7% of people with abnormal liver enzymes did not perform a repeating test during the study period.2 Malakouti et al. reviewed that abnormal liver enzymes might only be a normal physiological variation in some people, but it might reflect potential pathological changes in other cases and need further evaluation and management.3 The most common causes of pathologic changes are disorders of hepatocellular injury and disorders of cholestasis.3,4 A review of Agganis et al. disclosed that the three most common etiologies of abnormal liver enzymes are alcoholic toxicity, medication overdose, and fatty liver disease.4 Agganis et al. emphasized that even asymptomatic, any people having abnormal liver enzymes should receive further investigations including a detailed history taking and physical examination, followed by appropriate laboratory testing and other diagnostic workup.4 Therefore, the potential underlying causes can be found. The American College of Gastroenterology recommends a practice guideline regarding the evaluation of abnormal liver enzymes.5 This guideline is easily understood and performed in clinical practice. Primary care clinicians serve as the first-line healthcare providers and they should keep this guideline in mind. …
Literature
1.
go back to reference Bian J, Schreiner AD, Zhang J, Schumann SO, Rockey DC, Mauldin PD, et al. Associations of race with follow-up patterns after initial abnormal liver tests in primary care. J Gen Intern Med. 2018;33(10):1618–20. Bian J, Schreiner AD, Zhang J, Schumann SO, Rockey DC, Mauldin PD, et al. Associations of race with follow-up patterns after initial abnormal liver tests in primary care. J Gen Intern Med. 2018;33(10):1618–20.
2.
go back to reference Schreiner AD, Moran WP, Zhang J, Kirkland EB, Heincelman ME, Schumann Iii SO, et al. Evaluation of liver test abnormalities in a patient-centered medical home: do liver test patterns matter? J Investig Med. 2018;66(8):1118–23. Schreiner AD, Moran WP, Zhang J, Kirkland EB, Heincelman ME, Schumann Iii SO, et al. Evaluation of liver test abnormalities in a patient-centered medical home: do liver test patterns matter? J Investig Med. 2018;66(8):1118–23.
3.
go back to reference Malakouti M, Kataria A, Ali SK, Schenker S. Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do? J Clin Transl Hepatol. 2017;5(4):394–403.PubMedPubMedCentral Malakouti M, Kataria A, Ali SK, Schenker S. Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do? J Clin Transl Hepatol. 2017;5(4):394–403.PubMedPubMedCentral
4.
go back to reference Agganis B, Lee D, Sepe T. Liver enzymes: No trivial elevations, even if asymptomatic. Cleve Clin J Med. 2018;85(8):612–7.CrossRefPubMed Agganis B, Lee D, Sepe T. Liver enzymes: No trivial elevations, even if asymptomatic. Cleve Clin J Med. 2018;85(8):612–7.CrossRefPubMed
5.
go back to reference Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18–35.CrossRefPubMed Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18–35.CrossRefPubMed
Metadata
Title
Abnormal Liver Enzymes
Author
Shih-Wei Lai, MD
Publication date
01-09-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 9/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4790-2

Other articles of this Issue 9/2019

Journal of General Internal Medicine 9/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.